Envista Holdings Welcomes Paul Keel as CEO and Board Member

Envista Holdings Corporation (NYSE: NVST), a global leader in dental care comprising over 30 trusted dental brands such as Nobel Biocare, Ormco, DEXIS, and Kerr, has announced the appointment of Paul Keel as Chief Executive Officer and a member of the Board of Directors, effective May 1, 2024, succeeding Amir Aghdaei, who will provide support during the transition period as a senior advisor.

Keel brings a wealth of experience from Smiths Group plc and 16 years at 3M, where he held various leadership positions, including Group President of the Consumer Business Group and President of 3M Medical. His diverse background also includes leadership roles at GE, McKinsey & Company, and General Mills. Keel holds a BA from Carleton College and an MBA from Harvard Business School.

In his statement, Keel expresses his honor to lead Envista during a pivotal moment in its history, highlighting his admiration for the company and the dental industry. He underscores his commitment to building upon Envista’s strong foundation to serve stakeholders effectively, including customers, patients, colleagues, communities, and shareholders.

Keel’s appointment reflects Envista’s strategic vision for growth and innovation, with Scott Huennekens, Chairman of Envista, emphasizing Keel’s extensive experience and leadership in global innovation companies. Huennekens expresses confidence in Keel’s ability to drive Envista’s mission of digitizing, personalizing, and democratizing dental care, citing his proven track record in accelerating growth and operational excellence within the medical and oral care sectors.

Have you read?
Richest Billionaire Investors.
Billionaire Winners.
Billionaire Losers.
Best Business Schools.
Best Hotel Schools.